tiprankstipranks
Trending News
More News >
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market

BioCryst (BCRX) Cash flow

Compare
2,600 Followers

BioCryst Cash Flow

BCRX's free cash flow for Q3 2025 was $39.77M. For the 2025 fiscal year, BCRX's free cash flow was decreased by $44.16M and operating cash flow was $41.11M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -52.02M$ -95.14M$ -161.85M$ -142.16M$ -137.22M
Investing Cash Flow
$ 52.59M$ -131.50M$ -128.24M$ 15.80M$ -6.86M
Financing Cash Flow
$ -5.76M$ 32.48M$ 88.03M$ 359.67M$ 302.70M
End Cash Position
$ 106.32M$ 112.45M$ 306.24M$ 507.73M$ 274.35M
Free Cash Flow
$ -53.14M$ -97.31M$ -163.20M$ -144.54M$ -137.73M
Currency in USD

BioCryst Cash Flow